Ligand Pharmaceuticals (LGND) Leases (2019 - 2025)
Historic Leases for Ligand Pharmaceuticals (LGND) over the last 7 years, with Q3 2025 value amounting to $7.6 million.
- Ligand Pharmaceuticals' Leases rose 631.55% to $7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.6 million, marking a year-over-year increase of 631.55%. This contributed to the annual value of $9.7 million for FY2024, which is 5956.78% up from last year.
- As of Q3 2025, Ligand Pharmaceuticals' Leases stood at $7.6 million, which was up 631.55% from $8.0 million recorded in Q2 2025.
- Ligand Pharmaceuticals' 5-year Leases high stood at $32.1 million for Q3 2022, and its period low was $800000.0 during Q1 2025.
- Moreover, its 5-year median value for Leases was $9.7 million (2024), whereas its average is $11.9 million.
- Per our database at Business Quant, Ligand Pharmaceuticals' Leases skyrocketed by 29341.77% in 2021 and then plummeted by 8672.86% in 2025.
- Quarter analysis of 5 years shows Ligand Pharmaceuticals' Leases stood at $16.2 million in 2021, then plummeted by 75.31% to $4.0 million in 2022, then skyrocketed by 51.55% to $6.1 million in 2023, then skyrocketed by 59.57% to $9.7 million in 2024, then dropped by 21.34% to $7.6 million in 2025.
- Its Leases stands at $7.6 million for Q3 2025, versus $8.0 million for Q2 2025 and $800000.0 for Q1 2025.